APRE
APRE
NASDAQ · Biotechnology

Aprea Therapeutics Inc

$0.42
-0.02 (-5.41%)
As of Nov 14, 2:51 AM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +8,564.1% upside
Low Target $23.45
Average Target $36.06
High Target $38.88
Current Price $0.42
Current
$0.42
Target
$36.06
$23.45 $36.06 avg $38.88
Scenario Analysis
Bear Case
$23.45
5,534.3%
Low target
Base Case
$36.06
+8,564.1%
Avg target
Bull Case
$38.88
+9,241.7%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$1.49
-72.1% from high
52-Week Low
$0.41
+1.5% from low
Target vs 52W High
$36.06
+2,320.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.8%